150 related articles for article (PubMed ID: 38575994)
21. m6A-modified RIPK4 facilitates proliferation and cisplatin resistance in epithelial ovarian cancer.
Yin X; Zhao S; Zhang M; Xing J; Zhou J; Gao W; Chen L; Zhang Y; Lin L; Lu M; Li W; Shang J; Zhu X
Gynecol Oncol; 2024 Jan; 180():99-110. PubMed ID: 38086167
[TBL] [Abstract][Full Text] [Related]
22. STM2457 Inhibits the Invasion and Metastasis of Pancreatic Cancer by Down-Regulating BRAF-Activated Noncoding RNA N6-Methyladenosine Modification.
Hao S; Sun H; Sun H; Zhang B; Ji K; Liu P; Nie F; Han W
Curr Issues Mol Biol; 2023 Nov; 45(11):8852-8863. PubMed ID: 37998732
[TBL] [Abstract][Full Text] [Related]
23. RNA m6A methylation regulators in ovarian cancer.
Guo J; Zheng J; Zhang H; Tong J
Cancer Cell Int; 2021 Nov; 21(1):609. PubMed ID: 34794452
[TBL] [Abstract][Full Text] [Related]
24. METTL3-mediated m6A modification of lnc RNA RHPN1-AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K/AKT pathway.
Cui S
J Clin Lab Anal; 2022 Dec; 36(12):e24761. PubMed ID: 36336887
[TBL] [Abstract][Full Text] [Related]
25. N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells.
Lai J; Zhou Z; Hu K; Yu H; Su X; Niu X; Li H; Mao S
Epigenetics; 2024 Dec; 19(1):2298058. PubMed ID: 38145548
[TBL] [Abstract][Full Text] [Related]
26. Bone Marrow Mesenchymal Stem Cells Reversed Ovarian Aging-related m6A RNA Methylation Modification Profile in Aged Granulosa Cells.
Tian C; An Y; Zhao J; Zhu X; Wei W; Ruan G; Li Y; Pan X
Stem Cell Rev Rep; 2023 May; 19(4):953-967. PubMed ID: 36609903
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis of differences in N6-methyladenosine RNA methylomes in
Li H; Lin J; Cheng S; Chi J; Luo J; Tang Y; Zhao W; Shu Y; Liu X; Xu C
Front Cell Dev Biol; 2023; 11():1136096. PubMed ID: 37363723
[No Abstract] [Full Text] [Related]
28. Hsa_circ_0001756 promotes ovarian cancer progression through regulating IGF2BP2-mediated RAB5A expression and the EGFR/MAPK signaling pathway.
Ji J; Li C; Wang J; Wang L; Huang H; Li Y; Fang J
Cell Cycle; 2022 Apr; 21(7):685-696. PubMed ID: 35113003
[TBL] [Abstract][Full Text] [Related]
29. A Risk Score Model Incorporating Three m6A RNA Methylation Regulators and a Related Network of miRNAs-m6A Regulators-m6A Target Genes to Predict the Prognosis of Patients With Ovarian Cancer.
Li Q; Ren CC; Chen YN; Yang L; Zhang F; Wang BJ; Zhu YH; Li FY; Yang J; Zhang ZA
Front Cell Dev Biol; 2021; 9():703969. PubMed ID: 34631700
[TBL] [Abstract][Full Text] [Related]
30. The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer.
Xu Y; Song M; Hong Z; Chen W; Zhang Q; Zhou J; Yang C; He Z; Yu J; Peng X; Zhu Q; Li S; Ji K; Liu M; Zuo Q
J Exp Clin Cancer Res; 2023 Jan; 42(1):10. PubMed ID: 36609396
[TBL] [Abstract][Full Text] [Related]
31. [Characteristics of N6-methyladenosine modification patterns in t(8;21) acute myeloid leukemia].
Wen Y; Fang S; Yang J; Wang H; Jiao Y; Wang N; Wei Y; Wang L; Dou L
Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):690-697. PubMed ID: 35673912
[TBL] [Abstract][Full Text] [Related]
32. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B
J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
34. IGF2BP2 promotes the progression of ovarian endometriosis by regulating m6A-modified MEIS2 and GATA6.
Zhao S; Zhang B; Yuan H; Yin Y; Qi S; Li W; Wu X; Yaling F
Int J Biochem Cell Biol; 2022 Nov; 152():106296. PubMed ID: 36113831
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of m6A modification in lipopolysaccharide-induced acute lung injury in mice.
Xu C; Song C; Wang W; Liu B; Li G; Fu T; Hao B; Li N; Geng Q
Mol Med; 2024 Jan; 30(1):14. PubMed ID: 38254010
[TBL] [Abstract][Full Text] [Related]
36. METTL16 Inhibits the Malignant Progression of Epithelial Ovarian Cancer through the lncRNA MALAT1/
Li C; Liu J; Lyu Y; Ling S; Luo Y
Anal Cell Pathol (Amst); 2023; 2023():9952234. PubMed ID: 37927399
[TBL] [Abstract][Full Text] [Related]
37. Exposure to bisphenol A affects transcriptome-wide N6-methyladenine methylation in ovarian granulosa cells.
Zhang Y; Yan C; Xie Q; Wu B; Zhang Y
Ecotoxicol Environ Saf; 2024 Mar; 272():116071. PubMed ID: 38354435
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib.
Liu L; Zhang Z; Zhang G; Wang T; Ma Y; Guo W
J Transl Med; 2020 Sep; 18(1):357. PubMed ID: 32951601
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive Analysis of the Transcriptome-Wide m6A Methylome in Pterygium by MeRIP Sequencing.
Jiang Y; Zhang X; Zhang X; Zhao K; Zhang J; Yang C; Chen Y
Front Cell Dev Biol; 2021; 9():670528. PubMed ID: 34249924
[TBL] [Abstract][Full Text] [Related]
40. Toosendanin reduces cisplatin resistance in ovarian cancer through modulating the miR-195/ERK/β-catenin pathway.
Wang G; Li L; Li Y; Zhang LH
Phytomedicine; 2023 Jan; 109():154571. PubMed ID: 36610147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
